StockData
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc. (STRO) stock

STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$10.26+0.09 (+0.88%)

Close on Nov 11, 2026Market cap $170.12MP/E –Yield –

Sutro Biopharma statistics

70 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Q3 FY2026, expected soon
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$170.12M
$282.97M
Enterprise Value
$5.78M
$154.96M
PS Ratio
3.72
3.71

Enterprise valuationIndustry

EV / Sales
0.13
2.66

Share statisticsIndustry

Shares Change (YoY)
39.7%
10.9%
Shares Change (QoQ)
0.06%
0.51%
Float
16M
49M
Shares Held by Insiders
6.10%
11.6%
Shares Held by Institutions
99.4%
56.4%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
15.1%
-0.76%
Short % of Float
14.5%
9.06%
Short % of Shares Outstanding
13.6%
6.38%
Days to Cover
6.26
5.16

Stock price statisticsIndustry

52-Week High
$43.85
–
52-Week Low
$7.15
–
20-Day Moving Average
$9.97
–
50-Day Moving Average
$13.61
–
200-Day Moving Average
$22.81
–
Average True Range (14)
$0.94
–
Price Change (1 Week)
3.22%
-0.50%
Price Change (1 Month)
-6.81%
-0.33%
Price Change (3 Months)
-51.9%
-17.2%
Price Change (6 Months)
-74.1%
-20.1%
Price Change (YTD)
-11.3%
-20.1%
Price Change (1 Year)
27.3%
-19.3%
Price Change (3 Years)
-50.7%
-23.4%
Price Change (5 Years)
-94.7%
-76.4%
Average Volume (10 Days)
239,602
–
Average Volume (20 Days)
323,102
–
Average Volume (90 Days)
302,119
–
Relative Volume
0.45
0.73
Relative Strength Index (14)
42.4
47.6
Volatility (1 Year)
87.2%
80.2%
Beta (5 Years)
2.21
1.07

MarginsIndustry

Operating Margin
-319.6%
-37.1%
Pretax Margin
-395.5%
-12.1%
Profit Margin
-395.2%
-32.3%
EBITDA Margin
-306.3%
-25.0%

Returns on capitalIndustry

Return on Assets (ROA)
-79.1%
-40.3%
Return on Capital Employed (ROCE)
-103.2%
-37.7%

Financial positionIndustry

Current Ratio
3.32
3.30
Quick Ratio
3.22
2.37

GrowthIndustry

Revenue Growth (YoY)
-56.3%
6.82%
Revenue Growth (3Y CAGR)
14.8%
2.25%
Revenue Growth (5Y CAGR)
19.1%
6.41%

EfficiencyIndustry

Asset Turnover
0.20
0.40
Revenue Per Employee
$333.59K
$426.63K
Profits Per Employee
-$1.32M
-$680.86K
Employee Count
137
75
WACC
15.9%
10.1%

Income statement (TTM)Industry

Revenue
$45.70M
$66.56M
Operating Income
-$146.05M
-$20.20M
Pretax Income
-$180.73M
-$13.50M
Net Income
-$180.64M
-$21.57M
EBITDA
-$139.99M
-$16.36M
EPS (Diluted)
-$17.32
-$0.77

Balance sheetIndustry

Net Cash (Debt)
$164.35M
$16.31M
Net Cash Per Share
$9.91
$0.70
Equity (Book Value)
-$103.32M
$53.12M
Book Value Per Share
-$6.23
$1.49
Tangible Book Value
-$103.32M
$26.11M
Working Capital
$122.75M
$77.59M

Cash flow (TTM)Industry

Operating Cash Flow
-$145.17M
-$12.07M

Dividends and yieldsIndustry

Earnings Yield
-106.2%
-19.8%

Taxes and interestIndustry

Income Tax
-$96.00K
$79.50K

Scores and fair valueIndustry

Altman Z-Score
-8.74
0.28
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodSTROS&P 500DifferenceSTRO per yearS&P 500 per year
1 month-28.1%-2.4%−25.7 pts
3 months-59.0%-1.2%−57.9 pts
Year to date-11.3%+12.3%−23.6 pts
1 year+26.2%+12.4%+13.7 pts
3 years-50.7%+78.8%−129.5 pts-21.0%+21.4%
5 years-95.0%+75.2%−170.1 pts-45.0%+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M STRO shares were sold short on Oct 30, 2026, up 15.1% from the previous report, or 14.50% of the shares available to trade. At recent volumes it would take 6.3 days to buy them back. Over the last 20 sessions, 46.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,257,487+15.1%360,4856.3
Oct 15, 20261,960,929+6.1%313,0776.3
Sep 30, 20261,847,453-11.0%285,3226.5
Sep 15, 20262,076,152+14.7%346,6106.0
Aug 31, 20261,809,482-2.5%212,0308.5
Aug 14, 20261,855,694+6.4%344,5745.4
Jul 31, 20261,744,843+5.6%274,7606.3
Jul 15, 20261,652,824+21.4%370,5854.5
Jun 30, 20261,361,955+47.7%590,7962.3
Jun 15, 2026922,188+22.7%236,2083.9
May 29, 2026751,365-37.0%434,2011.7
May 15, 20261,193,156+22.1%212,7735.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?